Colistin-Resistant Acinetobacter baumannii Clinical Strains with Deficient Biofilm Formation
- PMID: 26666921
- PMCID: PMC4776000
- DOI: 10.1128/AAC.02518-15
Colistin-Resistant Acinetobacter baumannii Clinical Strains with Deficient Biofilm Formation
Abstract
In two pairs of clinical colistin-susceptible/colistin-resistant (Cst(s)/Cst(r)) Acinetobacter baumannii strains, the Cst(r) strains showed significantly decreased biofilm formation in static and dynamic assays (P < 0.001) and lower relative fitness (P < 0.05) compared with those of the Cst(s) counterparts. The whole-genome sequencing comparison of strain pairs identified a mutation converting a stop codon to lysine (*241K) in LpsB (involved in lipopolysaccharide [LPS] synthesis) in one Cst(r) strain and a frameshift mutation in CarO and the loss of a 47,969-bp element containing multiple genes associated with biofilm production in the other.
Copyright © 2016, American Society for Microbiology. All Rights Reserved.
Figures
Similar articles
-
Association of virulence gene expression with colistin-resistance in Acinetobacter baumannii: analysis of genotype, antimicrobial susceptibility, and biofilm formation.Ann Clin Microbiol Antimicrob. 2018 Jun 1;17(1):24. doi: 10.1186/s12941-018-0277-6. Ann Clin Microbiol Antimicrob. 2018. PMID: 29859115 Free PMC article.
-
Sub-minimum inhibitory concentrations of colistin and polymyxin B promote Acinetobacter baumannii biofilm formation.PLoS One. 2018 Mar 19;13(3):e0194556. doi: 10.1371/journal.pone.0194556. eCollection 2018. PLoS One. 2018. PMID: 29554105 Free PMC article.
-
Lipopolysaccharide loss produces partial colistin dependence and collateral sensitivity to azithromycin, rifampicin and vancomycin in Acinetobacter baumannii.Int J Antimicrob Agents. 2015 Dec;46(6):696-702. doi: 10.1016/j.ijantimicag.2015.07.017. Epub 2015 Sep 7. Int J Antimicrob Agents. 2015. PMID: 26391380
-
Colistin resistance of Acinetobacter baumannii: clinical reports, mechanisms and antimicrobial strategies.J Antimicrob Chemother. 2012 Jul;67(7):1607-15. doi: 10.1093/jac/dks084. Epub 2012 Mar 22. J Antimicrob Chemother. 2012. PMID: 22441575 Review.
-
Screening and deciphering antibiotic resistance in Acinetobacter baumannii: a state of the art.Expert Rev Anti Infect Ther. 2013 Jun;11(6):571-83. doi: 10.1586/eri.13.38. Expert Rev Anti Infect Ther. 2013. PMID: 23750729 Review.
Cited by
-
Acinetobacter baumannii: an evolving and cunning opponent.Front Microbiol. 2024 Jan 22;15:1332108. doi: 10.3389/fmicb.2024.1332108. eCollection 2024. Front Microbiol. 2024. PMID: 38318341 Free PMC article. Review.
-
Colistin Resistance in Acinetobacter baumannii: Molecular Mechanisms and Epidemiology.Antibiotics (Basel). 2023 Mar 4;12(3):516. doi: 10.3390/antibiotics12030516. Antibiotics (Basel). 2023. PMID: 36978383 Free PMC article. Review.
-
Phenotypic and genotypic characterization of clinical Pseudomonas aeruginosa.J Taibah Univ Med Sci. 2022 Nov 13;18(3):480-487. doi: 10.1016/j.jtumed.2022.10.012. eCollection 2023 Jun. J Taibah Univ Med Sci. 2022. PMID: 36818171 Free PMC article.
-
The deficiency of poly-β-1,6-N-acetyl-glucosamine deacetylase trigger A. baumannii to convert to biofilm-independent colistin-tolerant cells.Sci Rep. 2023 Feb 16;13(1):2800. doi: 10.1038/s41598-023-30065-5. Sci Rep. 2023. PMID: 36797306 Free PMC article.
-
In vitro evaluation of the antimicrobial activity of antiseptics against clinical Acinetobacter baumannii strains isolated from combat wounds.Front Microbiol. 2022 Oct 4;13:932467. doi: 10.3389/fmicb.2022.932467. eCollection 2022. Front Microbiol. 2022. PMID: 36267170 Free PMC article.
References
-
- López-Rojas R, McConnell MJ, Jiménez-Mejías ME, Domínguez-Herrera J, Fernández-Cuenca F, Pachón J. 2013. Colistin resistance in a clinical Acinetobacter baumannii strain appearing after colistin treatment: effect on virulence and bacterial fitness. Antimicrob Agents Chemother 57:4587–4589. doi:10.1128/AAC.00543-13. - DOI - PMC - PubMed
-
- Beceiro A, Moreno A, Fernández N, Vallejo JA, Aranda J, Adler B, Harper M, Boyce JD, Bou G. 2014. Biological cost of different mechanisms of colistin resistance and their impact on virulence in Acinetobacter baumannii. Antimicrob Agents Chemother 58:518–526. doi:10.1128/AAC.01597-13. - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
